⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HELP News
Cybin Inc. Common Stock
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
globenewswire.com
HELP
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
globenewswire.com
HELP
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
globenewswire.com
HELP
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
globenewswire.com
HELP
ICLR
JNJ
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
globenewswire.com
HELP
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
globenewswire.com
HELP
A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
globenewswire.com
HELP
DFTX
CMPS
JNJ
ATAI
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
globenewswire.com
HELP
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
prnewswire.com
HELP
A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening
prnewswire.com
GHRS
HELP
DFTX
JNJ
CMPS